STAAR Surgical Cash Flow from Operating Activities 2010-2023 | STAA
STAAR Surgical cash flow from operating activities from 2010 to 2023. Cash flow from operating activities can be defined as a company's cash flows from operations.
| STAAR Surgical Annual Cash Flow Ops (Millions of US $) |
|
|---|---|
| 2023 | $15 |
| 2022 | $36 |
| 2021 | $44 |
| 2020 | $21 |
| 2019 | $26 |
| 2018 | $13 |
| 2017 | $3 |
| 2016 | $1 |
| 2015 | $-2 |
| 2014 | $-8 |
| 2013 | $3 |
| 2012 | $3 |
| 2011 | $5 |
| 2010 | $-4 |
| 2009 | $1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $2.081B | $0.322B |
| Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $72.780B | 20.42 |
| Becton Dickinson (BDX) | United States | $68.110B | 19.27 |
| West Pharmaceutical Services (WST) | United States | $26.529B | 47.54 |
| Cardinal Health (CAH) | United States | $24.242B | 13.86 |
| Align Technology (ALGN) | United States | $20.454B | 39.49 |
| Cooper (COO) | United States | $18.834B | 28.50 |
| Labcorp (LH) | United States | $17.507B | 15.07 |
| Henry Schein (HSIC) | United States | $9.419B | 16.70 |
| DENTSPLY SIRONA (XRAY) | United States | $5.791B | 14.99 |
| Merit Medical Systems (MMSI) | United States | $4.697B | 25.74 |
| Patterson (PDCO) | United States | $2.267B | 10.86 |
| CONMED (CNMD) | United States | $2.192B | 19.88 |
| Atrion (ATRI) | United States | $0.784B | 41.86 |
| Lifevantage (LFVN) | United States | $0.085B | 10.98 |
| Pro-Dex (PDEX) | United States | $0.064B | 32.09 |
| Biolase (BIOL) | United States | $0.006B | 0.00 |